Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Next-Gen Sequencing
Conferences  \  European Lab Automation 2013  \  Next-Gen Sequencing  \  Agenda  \  Michael Schnekenburger
RegisterLogin

Michael Schnekenburger's Biography


Michael Schnekenburger, Team Leader, Laboratoire de Biologie Moléculaire et Cellulaire du Cancer

Sorry, There is currently no biography for this presenter.

Michael Schnekenburger Image

Translating Epigenetic Alterations in Leukemia into Biomarkers of the Disease and for Target Therapies with DNA Demethylating Drugs

Friday, 7 June 2013 at 09:15

Add to Calendar ▼2013-06-07 09:15:002013-06-07 10:15:00Europe/LondonTranslating Epigenetic Alterations in Leukemia into Biomarkers of the Disease and for Target Therapies with DNA Demethylating DrugsSELECTBIOenquiries@selectbiosciences.com

Aberrant DNA methylation patterns are a common hallmark of tumor cells. We will discuss the translational potential of these epimutations as cancer biomarkers and possible therapeutic strategies related to DNA demethylation.

Add to Calendar ▼2013-06-06 00:00:002013-06-07 00:00:00Europe/LondonNext-Gen SequencingSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors
Related Conferences
Organoids and Spheroids Europe 2024
Location: Rotterdam, The Netherlands
Date: 24/06/2024 - 25/06/2024


Organoids and Organ-on-a-Chip Asia 2023
Location: Tokyo, Japan
Date: 05/10/2023 - 06/10/2023


Regenerative Medicine & Cell Therapy Asia 2023
Location: Tokyo, Japan
Date: 05/10/2023 - 06/10/2023